Physiomics (PYC) RNS Announcements

Add to Alert list
Date Time Source Announcement
31 Aug 2021 07:00 AM
RNS
Physiomics hires Head of Business Development
19 Jul 2021 07:00 AM
RNS
Physiomics expands technical team
29 Jun 2021 09:16 AM
RNS
Director Dealing
21 May 2021 04:40 PM
RNS
Director Dealing
21 May 2021 07:00 AM
RNS
Contract awards
14 May 2021 07:00 AM
RNS
Contract award
11 May 2021 07:00 AM
RNS
Contract award
10 May 2021 07:00 AM
RNS
Trading update
09 Apr 2021 02:00 PM
RNS
Conference presentation
22 Mar 2021 07:00 AM
RNS
Director/PDMR Shareholding
12 Mar 2021 07:00 AM
RNS
Presentation and Q&A on Company's Interim Results
04 Mar 2021 07:00 AM
RNS
Interim Results Presentation
02 Mar 2021 10:12 AM
RNS
Issue of Options
01 Mar 2021 07:00 AM
RNS
Interim Results
15 Feb 2021 07:00 AM
RNS
ValiRx Agreement
18 Dec 2020 07:00 AM
RNS
Holding(s) in Company
17 Dec 2020 02:00 PM
RNS
Partnership with TRHC's DoseMeRx®
17 Dec 2020 07:00 AM
RNS
Merck Contracts
14 Dec 2020 07:00 AM
RNS
Approval of NIHR-funded PARTNER study
17 Nov 2020 12:59 PM
RNS
Result of AGM
22 Oct 2020 08:30 AM
RNS
Posting of Annual Report and AGM Notice
22 Oct 2020 07:00 AM
RNS
Posting of Annual Report and AGM Notice
16 Oct 2020 07:00 AM
RNS
Contract awards
06 Oct 2020 09:00 AM
RNS
Presentation and Q&A on Company's Final Results
30 Sep 2020 07:00 AM
RNS
Final Results and Notice of AGM
25 Sep 2020 07:00 AM
RNS
Full year results release date and shareholder Q&A
11 Sep 2020 07:00 AM
RNS
Holding(s) in Company
12 Aug 2020 07:00 AM
RNS
Director Dealing
05 Aug 2020 01:00 PM
RNS
Issue of Equity
05 Aug 2020 07:00 AM
RNS
Issue of Equity and Director Dealing
04 Aug 2020 07:00 AM
RNS
Trading update
31 Jul 2020 07:00 AM
RNS
Physiomics awarded contract by Astellas Pharma Inc
22 Jul 2020 11:45 AM
RNS
Share Price Movement
17 Jul 2020 09:00 AM
RNS
Price Monitoring Extension
06 Jul 2020 10:00 AM
RNS
Director dealing
30 Jun 2020 02:30 PM
RNS
Contract award and update
22 Jun 2020 07:00 AM
RNS
Conference presentation
10 Jun 2020 01:00 PM
RNS
Holding(s) in Company
27 May 2020 07:00 AM
RNS
Fundraise
15 May 2020 01:00 PM
RNS
Holding(s) in Company
28 Apr 2020 02:50 PM
RNS
Conference attendance and presentation
16 Apr 2020 07:00 AM
RNS
Confirmation of Twitter account
09 Apr 2020 12:28 PM
RNS
Holding(s) in Company
06 Apr 2020 07:00 AM
RNS
Awarded further Bicycle Therapeutics contract
19 Mar 2020 07:00 AM
RNS
COVID-19 update
10 Mar 2020 07:00 AM
RNS
NIHR i4i award
05 Mar 2020 07:00 AM
RNS
Physiomics awarded further contract by Merck
03 Mar 2020 07:01 AM
RNS
Interim Results
03 Mar 2020 07:00 AM
RNS
Awarded two further contracts by Bicycle
27 Dec 2019 03:45 PM
RNS
Holding(s) in Company

Physiomics plc is a UK-based company that uses mathematical models to help develop cancer treatments and personalized medicine. Services include Virtual Tumor modeling: A combination of proprietary and industry standard technologies that predict the effects of cancer treatments and drugs, Answering R&D questions: Helping clients de-risk drug development and build confidence in a molecule's clinical potential and Predicting therapeutic windows: Helping clients achieve a more quantitative understanding of new molecules.

PYC share price listed at 231p in 2004.

UK 100

Latest directors dealings